Integral Diagnostics Limited
IDX.AX
Get informed when a big investor buys or sells
+ FollowMarket Cap$802.09M
Close$
Share Statistics
| Market cap | $802.09 Million |
|---|---|
| Enterprise Value | $1.35 Billion |
| Dividend Yield | $0.09 (4.33%) |
| Earnings per Share | $0.06 |
| Beta | 0.15 |
| Outstanding Shares | 372,488,315 |
Return
| Return on Equity | 3.94% |
|---|---|
| Return on Assets | 1.82% |
| Return on Invested Capital | 8.94% |
Valuation & Multiples
| P/E Ratio | 36.56 |
|---|---|
| PEG | 23.44 |
| Price to Sales | 0.72 |
| Price to Book Ratio | 2.15 |
| Enterprise Value to Revenue | 0.95 |
| Enterprise Value to EBIT | 11.49 |
| Enterprise Value to Net Income | 50 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | 0.88 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 24, 2026
EPS Estimate
$0.06
Average shareholder expectationRevenue Estimate
$398.30 M
Average shareholder expectationNext Earnings Call
Expected Date
February 16, 2027
EPS Estimate
$0.06
Average shareholder expectationRevenue Estimate
$415.76 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Integral Diagnostics Limited
3,049 employees
CEO: Jason Martinez Integral Diagnostics Limited operates within the healthcare sector, providing essential diagnostic imaging services. These services are delivered to general practitioners, medical specialists, allied health professionals, and their patie...